GlassScriptPhysician profile
Ryan Pivovar
NPI 1205362233
$1,935.79
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $564 · 2021: $902 · 2022: $368 · 2023: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,088.56 | 2020-2023 | Prostep |
| Smith+Nephew, INC. | $328.24 | 2020-2022 | |
| Integra Lifesciences Corporation | $187.64 | 2021-2022 | |
| Horizon Therapeutics Plc | $80.43 | 2022 | |
| Treace Medical Concepts, INC. | $67.77 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $40.21 | 2021-2023 | Nuzyra |
| Abbvie INC. | $31.35 | 2022 | |
| Bioventus LLC | $19.57 | 2021 | |
| Aroa Biosurgery Incorporated | $18.84 | 2020 | |
| Depuy Synthes Sales INC. | $17.08 | 2020 | |
| Rock Medical Orthopedics, INC. | $15.76 | 2023 | |
| Kci USA, INC. | $14.84 | 2022 | |
| Arteriocyte Medical Systems, INC. | $14.44 | 2022 | |
| Heron Therapeutics, INC. | $11.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Pivovar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.